Ibrahimhalil Dusunceli

Ibrahimhalil Dusunceli

Auto-generated profile, based on publicly available information

Ibrahimhalil Dusunceli

Department of Gastroenterology and Hepatology, Faculty of Medicine, Zonguldak Bulent Ecevit University, Zonguldak, Türkiye

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2022 in Turkish Journal of Gastroenterology
Verified
Journal Article
Open access
ZSZeynep Gok Sargin
Zeynep Gok Sargin
IDİbRahimhalil Düşünceli
İbRahimhalil Düşünceli
ÜÇÜmüt Çelik
Ümüt Çelik
Background: The sudden and intense burden due to the novel coronavirus (coronavirus disease 2019) pandemic has changed the priority of many health services. The highly contagious new variants and vaccination services have greatly impacted the daily practice of gastroenterologists. In the present study, we tried to evaluate the change in the daily practice of Turkish gastroenterologists in the coronavirus disease 2019 pandemic and the post-vaccination periods. Methods: A questionnaire was prepared using Google forms and sent online to 214 gastroenterologists registered with the Turkish Gastroenterology Association. Results: Approximately half of the gastroenterologists moved their endoscopy unit or gastroenterology clinic to another location in the hospital during the pandemic and about one-third of the endoscopy units were completely closed. About 56% of the respondents reported the interruption of endoscopic procedures and inpatient services. In total, 85% of gastroenterologists thought that follow-up and treatment of chronic patients were disrupted due to patients obtaining their medicine directly from pharmacies. After the first case in Turkey, 74% of gastroenterologists worked in coronavirus disease 2019 patient care services, 28% of gastroenterologists were infected with coronavirus disease 2019, and 3% believed they had a cross-infected patient(s). A total of 78% of gastroenterologists reported that patient management became difficult due to the change in the priority of other departments, and 60% of gastroenterologists confirmed that they experienced a decrease in income. In the post-vaccination period, 70% of gastroenterologists returned to their pre-pandemic working schedule and 31% noticed an increase in endoscopic cancer detection. Conclusion: Prolongation of the pandemic has seriously damaged the practice of gastroenterology and multidisciplinary patient management. Cite this article as: Gök Sargın Z, Düşünceli İ, Çelik Ü. Effects of COVID-19 pandemic and post-vaccination period on gastroenterology practice in Turkey. Turk J Gastroenterol. 2023; 34(1): 13-18.

31 January 2025 in Biomarkers in Medicine
Verified
Journal Article
Closed access
IDIbrahimhalil Dusunceli
Ibrahimhalil Dusunceli
ZSZeynep Gok Sargin
Zeynep Gok Sargin
UCUmut Celik
Umut Celik
FSFatih Sargin
Fatih Sargin
Ulcerative colitis (UC) is an incurable disease represented by relapse and remission. Noninvasive biomarkers are required to predict disease activation. This study aimed to identify noninvasive biomarkers, such as the c-reactive protein-albumin (CRP/ALB) ratio, platelet-lymphocyte ratio (PLR), and neutrophil-lymphocyte ratio (NLR), that might forecast disease activation in UC. This retrospective study included 443 participants: 192 patients with active UC, 166 in remission, and 85 healthy controls. Mayo Endoscopic Subscore was employed to assess endoscopic disease activity. Serum CRP, erythrocyte sedimentation rate (ESR), ALB levels, and complete blood count characteristics were documented. Three ratios of inflammation-related indicators were identified as CRP/ALB, PLR, and NLR. A positive correlation was found between ESR, CRP, neutrophil count, platelet count, levels of CRP/ALB, PLR, NLR, and endoscopic activity. The CRP/ALB ratio demonstrated more efficacy than the NLR and PLR in differentiating the UC patients from the controls (p = 0.007, p = 0.003, respectively) and the active group from the remission group (p < 0.001, p < 0.001, respectively). Regression analysis revealed that the CRP/ALB was significantly able to distinguish active UC from the remission group and the controls (p < 0.001, p < 0.001, respectively). The CRP/ALB ratio could be useful as an independent predictive biomarker for disease activity in UC.

10 September 2020 in Medical Bulletin of Haseki
Verified
Journal Article
Closed access
IDİbrahim Halil Düşünceli
İbrahim Halil Düşünceli
MEMetin Ergül
Metin Ergül
NENecmi Eren
Necmi Eren
BKBetül Gönüllü Kalender
Betül Gönüllü Kalender
EDErkan Dervişoğlu
Erkan Dervişoğlu

27 December 2022 in Batı Karadeniz Tıp Dergisi
Verified
Journal Article
Open access
PDF file
ZSZeynep Gok Sargin
Zeynep Gok Sargin
DYDoğancan YILMAZ
Doğancan YILMAZ
IDİbrahimhalil Düşünceli̇
İbrahimhalil Düşünceli̇
YÜYücel Üstündağ
Yücel Üstündağ
Amaç:Kronik hepatit C (KHC) hastalarında, küratif etkinliği yüksek, direkt etkili antiviraller (DAA) ile tedavi sonrası uzun dönemde öz bakım, günlük aktiviteler, ağrı ve emosyonel açıdan hayat kalitesindeki değişimi değerlendirmeyi amaçladık. Gereç ve Yöntemler :KHC nedeniyle Ocak 2017 ile Haziran 2021 tarihleri arasında DAA tedavisi tamamlanmış olan hastalara günlük yaşam aktiviteleri, öz bakım yeterlilikleri, ağrı seviyeleri, anksiyete ve depresyon varlığını ölçen EQ-5D-3L Genel Yaşam Kalitesi Ölçeği soruları tedavi öncesi ve tedavi sonrası karşılaştırma yapmak amacıyla yöneltildi. DAA tedavisi ile kalıcı viral yanıt sonrası en az 12 ay geçmiş hastalar çalışmaya alındı. Bulgular:Çalışmaya alınan 90 hastanın ortalama takip süresi 40 ±17.3 aydı. DAA tedavisi sonrası en az bir yıl sonra tüm hastaların yaşam kalitesi indekslerinde tedavi öncesine göre anlamlı olarak artış izlenmiştir (p<0.001). Her parametre ayrı ayrı değerlendirildiğinde; hastaların %17’sinde hareket kapasitesinde (p=0.010), %10’unda öz bakım kapasitesinde (p=0.013), %12’sinde günlük olağan aktiviteleri yapma kapasitelerinde (p<0.002), %27’sinde ağrı/rahatsızlıklarında (p<0.001), %43’ünde anksiyete/depresyonlarında (p<0.001) anlamlı iyileşme izlenmiştir. Glekaprevir/pibrentasvir alan grupta beş parametrenin dördünde, Ombitasvir/Paritaprevir/Ritonavir/Dasabuvir alan grupta beş parametrenin üçünde ve Ledipasvir/sofosbuvir alan grupta ise beş parametrenin ikisinde tedavi sonrası anlamlı iyileşme izlenmiştir. Karaciğer sirozu olmayan hastaların tüm parametrelerinde anlamlı iyileşme izlenmiştir (sırasıyla, p=0.007, p=0.020, p=0.008, p<0.001 p<0.001). Sirozu olan hastalarda ise yalnızca anksiyete/depresyon durumlarında tedavi sonrası anlamlı iyileşme izlenmiştir (p=0.005). Sonuç :KHC hastalarında DAA tedavisi ile kalıcı viral yanıttan en az bir yıl sonra uzun vadede hayat kalitesinde iyileşme olduğu gösterildi. Bu sonuçlar glecaprevir/pibrentasvir alan ve sirozu olmayan hastalarda daha belirgindi. Aim :It was aimed to evaluate the long-term changes in self-care, daily activities, pain and emotional quality of life after treatment with direct-acting antivirals (DAA) in chronic hepatitis C (CHC) patients. Materials and Methods:EQ-5D-3L General Quality of Life Scale questions measuring activities of daily, self-care efficacy, pain levels, anxiety, and depression in patients who completed DAA treatment for CHC between January 2017 and June 2021 was used to compare before and after treatment. Patients at least 12 months after sustained viral response with DAA treatment were included in the study. Results:The mean follow-up period of 90 patients was 40 ±17.3 months. A significant increase was observed in the quality of life indices of all patients at least one year after DAA treatment (p<0.001). Mobility in 17% (p=0.010), self-care in 10% (p=0.013), usual activities in 12% (p=0.002), pain/discomfort in 27% (p<0.001), anxiety/discomfort in 43% of patients depression (p<0.001) showed a significant improvement. Significant improvement was observed in four of the five parameters in the glecaprevir/pibrentasvir group, in three of these parameters in the Ombitasvir/Paritaprevir/Ritonavir/Dasabuvir group, and in two in the Ledipasvir/sofosbuvir group. A significant improvement was observed in all parameters of patients without liver cirrhosis (respectively p=0.007, p=0.020, p=0.008, p<0.001, p<0.001), while a significant improvement was observed only in anxiety/depression states in patients with cirrhosis (p =0.005) Conclusion:DAA therapy in patients with CHC demonstrated long-term improvement in quality of life at least one year after sustained viral response. These results were more pronounced in patients without cirrhosis who received glecaprevir/pibrentasvir.

3 April 2026 in Medicine
Verified
Journal Article
Open access
IDIbrahimhalil Dusunceli
Ibrahimhalil Dusunceli
ZSZeynep Gök Sargin
Zeynep Gök Sargin
FSFatih Sargin
Fatih Sargin
Colonoscopy is the primary method for diagnosing colonic diseases and detecting precancerous lesions, thereby playing a crucial role in the prevention of colorectal cancer. However, the scientific quality and reliability of these videos require systematic assessment. In addition, the scientific quality of Turkish colonoscopy videos on YouTube remains unexplored. This study used internationally recognized scoring systems to assess the scientific quality of Turkish colonoscopy-related videos on YouTube. This cross-sectional study analyzed 156 Turkish-language YouTube videos on colonoscopy, with the inclusion criteria requiring a video duration between 30 seconds and 60 minutes. The main outcomes were video quality and information accuracy, which were measured using the Journal of the American Medical Association (JAMA), modified DISCERN (mDISCERN) score, colonoscopy data quality (C-DQS), and Global Quality Score (GQS) tools. The study included 156 videos that fulfilled the inclusion criteria. According to the mDISCERN score, 24.4%, 59%, and 16.7% of the videos were of poor, fair, and good quality, respectively. Only 12.8% of the videos met the JAMA’s quality criteria. The overall average score for each video source was low, with an average C-DQS score of 7.1/40. The JAMA, C-DQS, GQS, and mDISCERN scores for the videos designed to educate healthcare professionals were higher than those for videos designed for patient information or general culture/patient experience ( P < .001 for each). Significant correlations were found between the JAMA score, mDISCERN score, GQS, and C-DQS ( P < .001). Four independent quality assessment scales were used to evaluate Turkish-language YouTube videos on colonoscopy, with the results indicating suboptimal to moderate information quality. Online platforms, including YouTube, should implement strict quality control measures to ensure the accuracy of health-related videos.